Gain Therapeutics
GANX
GANX
24 hedge funds and large institutions have $5.05M invested in Gain Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 3 closing their positions.
Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
6
Closed
3
Calls
$54K
Puts
$29K
Net Calls
+$25K
Net Calls Change
-$9K
Top Buyers
| 1 |
1
Northern Trust
Chicago,
Illinois
|
$142K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$214K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$289K |
| 4 |
4
Millennium Management
New York
|
$41.7K |
| 5 |
XT
5
XTX Topco
George Town,
Cayman Islands
|
$37.4K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Simplex Trading
Chicago,
Illinois
| – | – | -8,650 | Closed |
|
|
HGERS
27
Householder Group Estate & Retirement Specialist
Scottsdale,
Arizona
| – | – | -2,500 | Closed |
|
|
CFGS
28
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|